Enter valid email.
POSTED: May 17, 2017
Dr. Daniel Petrylak talks about emerging biomarkers for prostate cancer.
Tags: biomarkers prostate cancer, prostate cancer, prostate cancer information, prostate cancer research, prostate cancer support, Uncategorized,
Posted: May 17, 2017
I can not afford $29.99 a month for adobe flash so I guess I can’t open your article.
Posted: May 20, 2017
I was diagnosed 7 years ago with T3b Prostate Cancer with a metastises in my pelvic bone and since then have been on a double blockade of Triptorelin (quarterly injections) and daily bicalutamide. My PSA is now rising and 3 months ago my oncologist took me off the bicalutimde after which my PSA jumped 140%. He has now prescribe 4 sessions of radiotherapy to the prostate itself and after that he will think about enzalutimide or abiraterone depending on the outcome.
My 1st cousin has breast cancer and is currently on Chemotherapy. This rather suggests that we may share a bracca gene?
So I found the biomarker information very interesting except I could not clearly distinguish the name of the breast cancer drug.
My cousin lives in Paris, France and I live in London, England.
Would these had been available 15 years ago when I was diagnosed.
Posted: May 19, 2017
Posted: Nov 01, 2018
Posted: Dec 10, 2018